Best Doctors in Italy — Get an Online Consultation

Prof. Deraco has dedicated his career to helping patients with complex cancers, particularly those affecting the peritoneum, a membrane in the abdomen. He began his medical career in 1989 at the Surgery and Experimental Oncology Departments of the Fondazione IRCCS, National Cancer Institute in Milan, Italy. Over the years, he has played a key role in advancing treatments for peritoneal surface malignancies (PSM). For more than a decade, he was the lead physician for the Peritoneal Surface Malignancies Program. Since 2017, he has served as the director of the Peritoneal Surface Malignancies Unit, where he continues to focus on providing cutting-edge care for his patients.

Prof. Deraco’s expertise is in specialized cancer treatments like Cytoreductive Surgery (CRS), Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC), and Pressurized Intra-Peritoneal Aerosolized Chemotherapy (PIPAC). These techniques aim to remove cancer and deliver heated chemotherapy directly to the abdomen, giving patients with PSM new hope. He has successfully treated over 1,200 patients using these advanced methods.

In addition to his clinical work, Prof. Deraco is a professor at Milan University, where he teaches future surgeons about peritoneal surface malignancies. His teaching extends internationally, as he has mentored over 30 postdoctoral fellows from prestigious institutions worldwide.

Prof. Deraco’s educational background is extensive. He earned his medical degree from the University of Messina in 1987 with top honors, followed by a specialization in general surgery five years later. His training continued in Paris, where he specialized in oncology at the prestigious Paris Dauphine University. He further honed his skills through fellowships in world-renowned institutions such as the Gustave Roussy Institute in France, the Royal Marsden Hospital in the UK, and the Washington Cancer Institute in the USA.

Throughout his career, Prof. Deraco has remained actively involved in research and professional organizations. He has published over 250 scientific articles and 25 book chapters, contributing to the advancement of cancer treatment globally. He serves on the board of multiple scientific societies dedicated to cancer research, including the Peritoneal Surface Oncology International Group (PSOGI) and the Italian Society for Loco-Regional Cancer Therapy (SITILO).

Education Dr. Castriota graduated in Medicine and Surgery from the University of Milan. He continued his postgraduate training at the University of Bologna where he obtained two specializations: the first one in Cardiology in 1992 and then in Radiology. From 1995 to 1996 he spent a period as a Fellow in the "Arizona Heart Institute" under the supervision of Professor Diethrich.

Research Dr. Castriota is an active member of some scientific societies, such as SIRM (Italian Society of Medical Radiology), Fellow of the Scientific College of the Italian Society of Invasive Cardiology (GISE), Fellow of the European Society of Cardiology (FESC), European Cardiovascular Interventional Society (EAPCI) and of ISES, International Society of Endovascular Specialist. He is the principal investigator of a recent Protected TAVR study, aimed at evaluating the effectiveness of a particular device for brain protection during aortic valve replacement surgery using the TAVI endovascular method.

Publications He is a member of the International Editorial Board of Eurointervention, speaker and chairman for the execution of live cases in national and international conferences.

Author of about 150 full-length publications

Author of over 20 chapters in specialized volumes

Awards: NHMRC Career Development Fellowship, Australian National Health and Medical Research Council, 2015.

Dr. Lolli is a highly accomplished orthopedic surgeon specializing in spine surgery, with over two decades of expertise in treating complex spinal conditions. Graduating with top honors in Medicine and Surgery from the prestigious University of Bologna in 2004, he further honed his skills by specializing in Orthopedics and Traumatology.

Currently, Dr. Lolli is a key member of the Neurosurgery and Spine Surgery Department at the renowned Maria Cecilia Hospital, where he focuses on advanced treatments for spinal deformities in both teenagers and adults. His extensive background includes over a decade of work at the world-renowned Rizzoli Orthopedic Institute, one of Europe’s top orthopedic centers, where he was a spine surgery specialist from 2003 to 2015.

Dr. Lolli’s surgical expertise is reflected in the more than 3.000 spine surgeries he has performed, particularly in correcting vertebral deformities such as scoliosis and kyphosis. His proficiency spans treating both congenital and neuromuscular scoliosis in children and adolescents, using state-of-the-art techniques like growing rods and VEPTR for early onset scoliosis. He is also highly skilled in advanced vertebral resection techniques, including Smith Petersen, Ponte, and pedicle subtraction osteotomies.

In addition to pediatric spine deformities, Dr. Lolli has vast experience addressing degenerative spine conditions, such as herniated discs, spondylolisthesis, and spinal stenosis, using both traditional and cutting-edge non-fusion techniques.

An active member of the AO Spine association, Dr. Lolli contributes to global education and research in spine care. His academic contributions are extensive, with over 30 publications in leading medical journals (Spine, European Spine Journal, The Spine Journal) and more than 100 reports presented at national and international conferences. He has also been a keynote speaker at numerous prestigious events, including the Global Spine Congress and the Bologna Spine Meeting.

Dr. Lolli’s dedication to advancing spine surgery and improving patient outcomes has made him a respected figure in the field, both in Italy and internationally.

Dr. Motti works at the Neurosurgery Department at Maria Cecilia Hospital, as the coordinator of the Gamma Knife Operating Unit, and neurosurgeon in charge of the Stereotaxic Neurosurgery Unit, one of the few centers in Italy, which specializes in the Gamma Knife treatments.  

He is an active member of several research companies focused on Gamma Knife: Italian Society of Neurosurgery, Rome; Gamma Knife Society, Stockholm; European Gamma Knife Society, Madrid. In 1982 he obtained the patent for interfacing the Talairach stereotaxic helmet with computerized axial tomography methods. In 1987 he made the first brain implantation of dopaminergic cells in Parkinson's disease in Italy. He is responsible for training courses at national and international levels, such as courses in Stereotaxic Techniques, Functional Neurosurgery, Radiosurgery at the School of Specialization in Neurosurgery, by the University of Milan; He was an Invited speaker at the "Compliance in radiosurgery" course at the GKSociety meeting in Seoul, South Korea; Organizer of the First European Meeting of Gamma Knife Users, in 1996 in Milan and its subsequent editions.

He is often invited as an instructor in the first weeks of the opening of the new Gamma Knife centers, such as from the Hospital of the University of California Davis, Sacramento, California; or the Arsenji Hospital in Bucharest, Romania etc.

Author and co-author of about 100 publications and contributors to national and international journals. In the seventies he contributed as Assistant Editor to the editorial board of the Journal of Neurosurgical Sciences. For twenty years he was a Consultant in medical libraries as an expert in research techniques and bibliographic archives.

Head of the Orthopedics Department, Orthopedic Surgeon

Dr. Francesco Bedogni is an Interventional Cardiologist at San Donato Hospital in Milan and a European proctor for TAVI and MITRACLIP. He is a board member of the Italian Society of Interventional Cardiology and is responsible for multiple clinical studies and position papers.

Dr. Andrés J.M. Ferreri is a medical oncologist with over 300 scientific papers published related to lymphoma treatment. He is a Deputy Director at the Hematology Oncology Department and Director of the Lymphoma Unit at the San Raffaele Scientific Institute, as well as Founder of the Italian Lymphoma Foundation. He is a member of various prestigious medical organizations and a Contract Professor of Oncology at the Università Vita-Salute San Raffaele.

Professor Michele Reni is an experienced medical oncologist with over 30 years of practice based in Italy. He specializes in pancreatic adenocarcinoma, gastro-esophageal cancers, and central nervous system tumors. He has published over 180 papers on cancer treatment and is the coordinator of Italian Association of Medical Oncology (AIOM) guidelines for treatment and management of pancreatic cancer. He has also chaired numerous clinical trials on treating patients with metastatic pancreatic cancer.

Professor Fabio Carmignani is a specialist in andrology, urology, and prostatic biopsy under MRI guidance. He has been the Director of the Urology Department at Policlinico San Donato Research Hospital in Milan since 2007 and has over 10,000 surgeries to his credit. He has a medical degree from the University of Milan and is the President of the Foundation of the Italian Society of Urology. He has written over 100 research materials in urologic surgery and is a member of the American Urological Association and the Italian Society of Urology, Minimal Invasive Therapy.